CannaPharmaRX, Inc. provided revenue guidance for the full year 2023. For the year, the company expected revenue to be $30 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 USD | +3.09% | 0.00% | +488.24% |
05-16 | CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-14 | CannaPharmaRX, Inc. Receives First Purchase Order and Begins Shipment of Product | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+488.24% | 6.35M | |
+38.00% | 705B | |
+32.82% | 583B | |
-3.69% | 364B | |
+20.10% | 332B | |
+4.91% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.74% | 169B |
- Stock Market
- Equities
- CPMD Stock
- News CannaPharmaRX, Inc.
- CannaPharmaRX, Inc. Provides Revenue Guidance for the Full Year 2023